Enanta Pharmaceuticals, Inc. (ENTA) was a big mover last session, as the company saw its shares rise by over 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company, as the stock is now up 24.2% in the past one-month time frame.
This biotechnology stock has seen a lack of estimate revisions in the past one month. Thus, the Zacks Consensus Estimate has remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Enanta Pharmaceuticals currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.
Apart from Enanta Pharmaceuticals, investors interested in the med-drugs industry may also consider stocks such as Jazz Pharmaceuticals Public Limited Company (JAZZ), Questcor Pharmaceuticals, Inc. (QCOR) and Sucampo Pharmaceuticals, Inc. (SCMP). All these stocks carry the same rank as Enanta Pharmaceuticals.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
ENANTA PHARMACEUTICALS INC (ENTA): Free Stock Analysis Report
JAZZ PHARMACEUTICALS PLC IRELAND (JAZZ): Free Stock Analysis Report
QUESTCOR PHARMACEUTICALS INC (QCOR): Free Stock Analysis Report
SUCAMPO PHARMACEUTICALS CL A (SCMP): Free Stock Analysis Report
Zacks Investment Research
- Health Care Industry
- Finance Trading